Recombinant Oncolytic Vaccinia Viruses Expressing Human β-Defensin 2 Enhance Anti-tumor Immunity

Cancer is still a leading of cause of death worldwide. Among the bio-therapy strategies for cancer, vaccinia virus (VV) has been widely used as an expression vector because of its potent oncolytic activities in addition to its large capacity for insertion of foreign genes and excellent safety record...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ting, Luo, Yanxi, Wang, Minglong, Xie, Tian, Yan, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463222/
https://www.ncbi.nlm.nih.gov/pubmed/31011627
http://dx.doi.org/10.1016/j.omto.2019.03.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463222/
https://www.ncbi.nlm.nih.gov/pubmed/31011627
http://dx.doi.org/10.1016/j.omto.2019.03.010

Ejemplares similares